Page 19 - 2021年14期

[ 9 ] 李歆晨.全球吸入制剂市场分析及发展预测[EB/OL]. [20] U.S. Food and Drug Administration. Draft guidance on
[2020-08-04]. https：//mp.weixin.qq.com/s/dMYl63mhJbI- budesonide，formoterol fumarate dihydrate[EB/OL]. [2020-
NwyF3Zrr0Vw#rd.％202019-10-12.2019-10-12. 08-04]. https：//www.accessdata.fda.gov/drugsatfda_docs/
[10] 胡家嘉.吸入制剂行业专题报告：高技术壁垒突破在即， psg/Budesonide％ 20and％ 20Formoterol％ 20fumarate％
一 片 蓝 海 待 掘 金 [EB/OL].（2020-01-18）[2020-08-04]. 20dihydrate_MDI_021929_RC06-15.pdf.
https：//www.vzkoo.com/news/2488.html. [21] U.S. Food and Drug Administration. Draft guidance on al-
[11] 林小伟，吴佳青.创新药深度研究系列三：吸入制剂：攀登 buterol sulfate[EB/OL].[2020-08-04]. https：//www.access-
化学仿制药的巅峰[EB/OL].（2019-12-24）[2020-08-04]. data.fda.gov/drugsatfda_docs/psg/Albuterol％ 20sulfate_
http：//pdf.dfcfw.com/pdf/H3_AP201912241372524820_1. metered％ 20inhalation％ 20aerosol_RLD％ 2020503；％
pdf. 2020983；％2021457_RV12-16.pdf.
[12] 中国吸入制剂创新正当时[EB/OL].（2020-08-01）[2020-08- [22] U.S. Food and Drug Administration. Draft guidance on
04]. https：//xw.qq.com/cmsid/20200801A0582200. fluticasone propionate，salmeterol xinafoate[EB/OL].[2020-
[13] CPhI 制药在线.中国市场吸入制剂的江湖布局[EB/OL]. 08-04]. https：//www.accessdata.fda.gov/drugsatfda_docs/
（2020-06-09）[2020-08-04]. https：//med.sina.com/arti-
psg/Fluticasone％20Propionate；％20Salmeterol％20Xi-
cle_detail_103_2_83819.html.
nafoate％20Inhalation％20Aerosol％20Metered％20NDA％
[14] 国家药品监督管理局药品审评中心.国家药监局药审中
20021254％20PSG％20Page％20RC％20May％202019.
心发布《经口吸入制剂仿制药生物等效性研究指导原
pdf.
则》的通告：2020年第49号[Z].2020-12-15.
[23] European Medicines Agency. Pharmaceutical quality of in-
[15] U.S. Food and Drug Administration. Nasal spray and inha-
halation and nasal products[EB/OL].（2006-06-21）[2020-
lation solution，suspension，and spray drug products：
08-04]. https：//www.ema.europa.eu/en/pharmaceutical-
chemistry，manufacturing，and controls documentation[EB/
quality-inhalation-nasal-products.
OL]. [2020-08-04]. https：//www.fda.gov/regulatory-infor-
[24] European Medicines Agency. Guideline on the require-
mation/search-fda-guidance-documents/nasal-spray-and-
ments for clinical documentation for orally inhaled pro-
inhalation-solution-suspension-and-spray-drug-products-
ducts[EB/OL].（2009-01-22）[2020-08-04]. https：//www.
chemistry-manufacturing-and.
ema.europa.eu/en/documents/scientific-guideline/guideline-
[16] U.S. Food and Drug Administration. Integration of dose-
requirements-clinical-documentation-orally-inhaled-pro-
counting mechanisms into MDI drug products[EB/OL].
ducts-oip-including-requirements_en.pdf.
[2020-08-04]. https：//www.fda.gov/regulatory-information/
search-fda-guidance-documents/integration-dose-counting- [25] 国家食品药品监督管理局.关于发布吸入制剂质量控制
mechanisms-mdi-drug-products. 等5个药物研究技术指导原则的通知：国食药监注〔2007〕
[17] U.S. Food and Drug Administration. Metered dose inhaler 643号[Z]. 2007-10-23.
（MDI）and dry powder inhaler（DPI）drug products：quali- [26] 国家食品药品监督管理局.关于印发已上市吸入气雾剂
ty considerations[EB/OL].[2020-08-04]. https：//www.fda. 变更抛射剂研究技术要求的通知：国食药监注〔2011〕
gov/regulatory-information/search-fda-guidance-docu- 185号[Z]. 2011-04-22.
ments/metered-dose-inhaler-mdi-and-dry-powder-inha- [27] 国务院深化医药卫生体制改革领导小组.国务院深化医
ler-dpi-drug-products-quality-considerations. 药卫生体制改革领导小组印发关于以药品集中采购和
[18] U.S. Food and Drug Administration. Draft guidance on ip- 使用为突破口进一步深化医药卫生体制改革若干政策
ratropium bromide[EB/OL]. [2020-08-04]. https：//www. 措施的通知：国医改发〔2019〕3号[Z]. 2019-11-29.
accessdata.fda.gov/drugsatfda_docs/psg/Ipratropium％ [28] 吴明慧，刘强，滕晓茗.雾化吸入治疗的研究进展[J].中国
20bromide_MDI_021527_RC03-15.pdf. 临床新医学，2018，11（11）：1167-1171.
[19] U.S. Food and Drug Administration. Draft guidance on [29] 周利军，磨国鑫.呼吸系统疾病治疗用雾化吸入抗菌药物
levalbuterol tartrate[EB/OL].[2020-08-04]. https：//www. 的研究进展[J].现代药物与临床，2018，33（7）：1848-
accessdata.fda.gov/drugsatfda_docs/psg/Levalbuterol％ 1853.
20tartrate_draft_Inhalation％20aerosol％20metered_RLD％ （收稿日期：2021-02-09 修回日期：2021-06-21）
2021730_RC06-15.pdf. （编辑：孙 冰）

中国药房 2021年第32卷第14期 China Pharmacy 2021 Vol. 32 No. 14 ·1677 ·